cfo

The CFO will play a pivotal role in shaping the company's financial strategy, investor engagement, and IPO readiness.

This executive will serve as a key bridge between scientific innovation and capital market value creation, guiding the organization through a transformative phase toward becoming a publicly listed company.

客户简介

The employer is a clinical-stage biopharma company focused on metabolic and immunology diseases. As a mid-sized organization, it is funded through Pre-IPO stage and is advancing its therapeutic programs through Phase 2/3 clinical trials.

工作内容

Key Responsibilities:

Strategic Financial Leadership

• Lead the company's overall financial and capital strategy in alignment with corporate goals and IPO milestones.
• Drive budgeting, forecasting, and capital allocation to support R&D, BD, and commercialization priorities.
• Partner closely with the CEO, Board, and senior management to influence strategic decision-making and long-term value creation.

IPO Execution & Capital Markets

• Oversee all aspects of the Hong Kong IPO (HKEX) process, including audit, compliance, due diligence, and prospectus preparation.
• Liaise effectively with investment banks, auditors, legal counsel, and regulators.
• Ensure corporate governance and financial reporting standards meet global best practices.

Investor Relations & Fundraising

• Develop and maintain strong relationships with institutional investors, analysts, and key financial partners.
• Lead fundraising activities including private placements and pre-IPO rounds.
• Communicate the company's financial and scientific vision effectively to the global investment community.

理想的求职者

Graduated from a top-tier university; advanced degree (MBA, PhD preferred) and equivalent qualification (CPA/CFA) strongly desired.

• Proven success in leading or playing a key role in a Hong Kong IPO (HKEX) is a must
• Minimum 10-15 years of experience in finance, investment banking, or corporate development.
• Strong background in biotechnology, pharmaceutical, or life sciences industries.
• Deep understanding of capital markets, fundraising, M&A, and investor relations.
• Strategic mindset with hands-on execution capability.
• Exceptional communication and leadership presence.
• Bilingual proficiency in Chinese and English; Cantonese is a plus.

福利待遇

• Competitive salary starting at $300000 USD plus stock option
• Comprehensive benefits, including housing and transportation.
• Opportunity to work in a mid-sized, innovative clinical-stage biopharma company.
• Chance to contribute to ground breaking therapies for metabolic diseases.

If this role aligns with your expertise and career goals, we encourage you to apply and be part of an impactful journey in the life sciences industry.

Desired Skills and Experience
Proven success in leading or playing a key role in a Hong Kong IPO (HKEX) is a must

Minimum 10-15 years of experience in finance, investment banking, or corporate development.

Strong background in biotechnology, pharmaceutical, or life sciences industries.

Deep understanding of capital markets, fundraising, M&A, and investor relations.

Strategic mindset with hands-on execution capability.

Exceptional communication and leadership presence.

Bilingual proficiency in Chinese and English; Cantonese is a plus.

MPI does not discriminate on the basis of race, religion, sex, sexual orientation, gender identity or expression, age, disability, marital status, or based on an individual's status in any group or class otherwise protected under applicable human rights legislation. MPI encourages applications from minorities, women, the disabled and all other qualified applicants